Farid H A, Kamal S A, Weil G J, Adham F K, Ramzy R M R
Research and Training Centre on Vectors of Diseases, Faculty of Science, Ain Shams University Cairo, Egypt.
East Mediterr Health J. 2003 Jul;9(4):863-72.
The elimination strategy for lymphatic filariasis aims at reducing blood microfilaraemia to levels at which vector transmission cannot be sustained. We aimed to determine whether patients with pre-treatment low or ultra-low microfilaria (MF) counts could be a reservoir of infection after mass drug administration (MDA) with a combined regimen. Laboratory-reared mosquitoes were fed on 30 volunteers after 2 rounds of MDA. Microfilaria uptake, infectivity rates and number of Wuchereria bancrofti L3 per mosquito were assessed. One year after MDA-1, 6 subjects transmitted MF, but up to 9 months after MDA-2 transmission failed. Six months after MDA-2 > 90% had clear MF smears and either failed to transmit MF or transmitted MF that did not develop to L3. We conclude that the transmission cycle is seriously weakened after MDA-2.
淋巴丝虫病消除战略旨在将血液中微丝蚴血症降低到无法维持病媒传播的水平。我们旨在确定,在采用联合方案进行大规模药物给药(MDA)后,治疗前微丝蚴(MF)计数低或极低的患者是否会成为感染源。在两轮MDA之后,用实验室饲养的蚊子叮咬30名志愿者。评估微丝蚴摄取量、感染率以及每只蚊子体内班氏吴策线虫L3的数量。MDA-1一年后,6名受试者传播了MF,但MDA-2后长达9个月传播失败。MDA-2六个月后,超过90%的受试者MF涂片结果为阴性,要么未能传播MF,要么传播的MF未发育至L3。我们得出结论,MDA-2后传播周期严重减弱。